全球羊膜市场 – 行业趋势及 2029 年预测

市场分析和规模

羊膜是从女性胎盘中提取的最深层胎儿膜，用作严重创伤、烧伤皮肤、慢性伤口等病例的移植材料。由于成本效益疗法开发的技术进步，羊膜市场在 2022 年至 2029 年的预测期内可能会大幅增长。由于羊膜移植的增加、有关羊膜移植益处的知识和教育的增加以及老年人口的增加，预计市场将得到发展。

Data Bridge Market Research 分析，羊膜市场规模从 2021 年的 13.2629 亿美元飙升至 2029 年的 31.232 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 11.30%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

The amniotic membrane, also called the amnion, is the placenta's innermost layer. A thick foundation membrane and an avascular stromal matrix make up this structure. In different surgical specialisations, amniotic membrane transplantation has been used as a graft or as a dressing. In pterygium surgery, amniotic membrane tissue is transplanted after the aberrant tissue on the corneal side is peeled away without injuring the underlying corneal tissue.

Amniotic Membrane Market Dynamics

Drivers

• High incidence of burn wound cases

According to WHO, the majority of burn incidents occur in low- and middle-income countries, with over two-thirds happening in Africa and Southeast-Asia. Because burn wounds are so common, demand for wound care biologics such as amniotic membranes has skyrocketed. In India, one million people suffer from mild to severe burns each year (Source: WHO). Burns are also common in other Southeast Asian nations like Bangladesh and Nepal. The amniotic membrane burn therapy market is growing because it is effective in treating severe burn wounds.

• Rising craze to look flawless

Physical beauty has become one of the most important components of one's personality, and maintaining a faultless appearance is one of today's most popular trends. Amniotic tissues aid in the healing of wounds and burns. In recent years, Indians have embraced a high number of ophthalmology and cosmetic surgical treatments, which is likely to boost the expansion of amniotic membrane product suppliers in the country. Due to an increase in amniotic dry eye therapy, India's market is predicted to grow by double digits. Amniotic membranes are often used as a biological bandage to heal or replace injured eye tissues during eye procedures. The expanding popularity of dry eye amniotic membrane therapy, increased awareness among the general public, increasing amniotic membrane application, and growing popularity of skin care treatments are all likely to boost demand for amniotic goods in the country over the forecast period.

• Dry eye amniotic membrane treatment largely popular in the U.S.

The United States is likely to provide a large amount of revenue, since the country's chronic wound industry offers enormous opportunities for amniotic membrane suppliers. Because of the widespread use of amniotic membrane therapy for dry eye surface concerns has been included in ocular treatments. As a result of the growing number of ophthalmic surgeries performed in the United States as a result of the ageing population, the entire market is expanding significantly.

Opportunities

• Amniotic tissues and amniotic membrane fluid-promising treatment methods

The global amniotic membrane market is expected to be driven by the ageing population, expansion of amniotic membrane transplant indications, increased research and development
(R&D) investments in AMT by key players, increased focus on amniotic tissues cell and stem cell research, unmet clinical needs, regulatory harmonisation, and other factors.

Amniotic tissues and amniotic membrane fluid can be used to treat chronic plantar fasciosis and achilles tendinosis. Amniotic tissues can be used as a skin graft without having to worry about tissue typing or matching the donor to the receiver. As a result, amniotic membranes and amniotic membrane fluid could be used in new allografts and stem cell therapies for degenerative diseases. The ophthalmology market is predicted to increase gradually in the next years, primarily to the increasing use of tissue-based products in ocular treatments due to their speedy recovery properties, such as lowering inflammation and improving healing.

Restraints/Challenges

However, in the forecast period 2022 to 2029, limits on the usage of amniotic membranes and strict government regulations may impede the growth of the Europe amniotic membrane market. AM is now being researched for application in the treatment of cancer, lung injury, and other internal organ damage. Despite the positive results of lung damage treatment, the use of this treatment on patients is still up in the air. Because of the limited use of AM on skin tissues and some external organs, it has come to a halt in other therapies, and more study is undertaken. As a result, it is the only roadblock to AM's usage in medical treatment of chronic disorders in humans.

This amniotic membrane market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the amniotic membrane market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Amniotic Membrane Market

The COVID-19 outbreak had a negative influence on the amniotic goods industry in 2020 due to widespread lockdowns, refused wound care treatments, and cancelled or postponed elective surgeries. Elective operations were rejected (cancelled/postponed) so that scarce capacities and resources (such as hospital beds and patient care professionals) may be allocated or redirected to COVID-19 patient care. Several countries also implemented lockdowns and curfews to combat the rising number of COVID-19 cases. Lockdowns prevented patients from visiting hospitals, outpatient clinics, or clinics. This temporary stoppage of freefone healthcare services is expected to delay the market for amniotic goods. However, demand for amniotic products is expected to rise dramatically in the coming years.

Recent Development

• According to the Europe Transport Safety Council, the number of road deaths per million people in the European Union was 42 in 2020.
• In April 2021, SurgiLogix will debut their SXDBMTM Fiber allograft, which is made completely of demineralized cortical bone and does not require a carrier. When 100 percent demineralized cortical bone is hydrated with any bioactive ingredient, it creates a malleable fibrous structure that can be utilised to fix bony cavities or gaps. It absorbs blood, BMA, or PRP fast and forms a superior osteoconductive scaffold with increased osteoinductive potential.

Global Amniotic Membrane Market Scope

The amniotic membrane market is segmented on the basis of type, product, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Cryopreserved
• Lyophilized

Application

• Surgical Wounds
• Ophthalmology
• Others

End-User

• Hospitals
• Specialized Clinics
• Ambulatory Surgical Centres
• Academic Research Centres

Amniotic Membrane Market Regional Analysis/Insights

The amniotic membrane market is analysed and market size insights and trends are provided by country, type, product, application and end-user as referenced above.

The countries covered in the amniotic membrane market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

由于对替代技术的关注度增加以及现代技术的采用，北美将主导市场，预计这将在 2022 年至 2029 年的预测期内推动该领域的市场扩张。

预计亚太地区在预测期内将以显著的复合年增长率增长。该地区大多数国家经济都在增长，可支配收入不断增加，多家跨国公司已在该地区进行了大量投资。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。 

医疗保健基础设施增长安装基础和新技术渗透

羊膜市场还为您提供每个国家/地区资本设备医疗支出增长、羊膜市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对羊膜市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。

竞争格局和羊膜 市场份额分析

羊膜市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对羊膜市场的关注有关。

羊膜市场的一些主要参与者包括：

• Tissue-Tech Inc.（美国）
• 应用生物制剂（美国）
• LifeLike BioTissue（美国）
• Celularity Inc,（美国）
• Labtician Ophthalmics Inc. (加拿大)
• Smith+Nephew（英国）
• 史赛克（美国）
• WWW.SURGILOGIX.COM.（美国）
• Integra LifeSciences（美国）
• MiMedx（美国）
• Skye Biologics Holdings LLC（美国）
• Amniox Medical Inc（美国）
• 人类再生技术有限责任公司（美国）
• Katena Products Inc（美国）
• Amnio Technology, LLC（美国）

SKU-68484